Try our Advanced Search for more refined results
July 24, 2020
UCB, Inc. et al v. Annora Pharma Private Limited et al
Case Number:
1:20-cv-00987
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 16, 2023
Delaware Federal Judge Upholds UCB's Epilepsy Drug Patent
A top federal judge in Delaware decided Wednesday that three generic-drug makers failed to prove a claim in a patent for an ingredient in a popular seizure drug should never have been issued by the patent office, sinking their efforts to compete with the drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login